1. Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System. (March 2019) Authors: Naganuma, Misa; Tahara, Kohei; Hasegawa, Shiori; Fukuda, Akiho; Sasaoka, Sayaka; Hatahira, Haruna; Motooka, Yumi; Nakao, Satoshi; Mukai, Ririka; Hirade, Kouseki; Yoshimura, Tomoaki; Kato, Takeshi; Takeuchi, Hirofumi; Nakamura, Mitsuhiro Journal: SAGE open medicine Issue: Volume 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database. (26th April 2018) Authors: Naganuma, Misa; Motooka, Yumi; Sasaoka, Sayaka; Hatahira, Haruna; Hasegawa, Shiori; Fukuda, Akiho; Nakao, Satoshi; Shimada, Kazuyo; Hirade, Koseki; Mori, Takayuki; Yoshimura, Tomoaki; Kato, Takeshi; Nakamura, Mitsuhiro Journal: SAGE open medicine Issue: Volume 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database. (May 2020) Authors: Matsumoto, Kiyoka; Nakao, Satoshi; Hasegawa, Shiori; Matsui, Toshinobu; Shimada, Kazuyo; Mukai, Ririka; Tanaka, Mizuki; Uranishi, Hiroaki; Nakamura, Mitsuhiro Journal: SAGE open medicine Issue: Volume 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database. Issue 10 (1st September 2020) Authors: Hasegawa, Shiori; Ikesue, Hiroaki; Nakao, Satoshi; Shimada, Kazuyo; Mukai, Ririka; Tanaka, Mizuki; Matsumoto, Kiyoka; Inoue, Misaki; Satake, Riko; Yoshida, Yu; Goto, Fumiya; Hashida, Tohru; Nakamura, Mitsuhiro Journal: Pharmacoepidemiology and drug safety Issue: Volume 29:Issue 10(2020) Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessment of Reye's syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis. (November 2020) Authors: Matsumoto, Kiyoka; Hasegawa, Shiori; Nakao, Satoshi; Shimada, Kazuyo; Mukai, Ririka; Tanaka, Mizuki; Satake, Riko; Yoshida, Yu; Goto, Fumiya; Inoue, Misaki; Ikesue, Hiroaki; Iguchi, Kazuhiro; Hashida, Tohru; Nakamura, Mitsuhiro Journal: SAGE open medicine Issue: Volume 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report. Issue 12 (March 2019) Authors: Nakao, Satoshi; Masuda, Takeshi; Sakamoto, Shinjiro; Yamaguchi, Kakuhiro; Horimasu, Yasushi; Miyamoto, Shintaro; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Hamada, Hironobu; Hattori, Noboru Other Names: NA. section editor. Journal: Medicine Issue: Volume 98:Issue 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of Liquid-Chromatography Tandem-Mass-Spectrometry Method for Determining Environmental Contamination by Powdered Medicinal Drugs in Pharmacies. (12th November 2021) Authors: Hasegawa, Shiori; Inaba, Ryoichi; Nakamura, Hiroki; Kato, Yamato; Nakao, Satoshi; Hirade, Kouseki; Suzuki, Takaaki; Iwata, Mari; Kato, Takeshi; Iguchi, Kazuhiro; Yamada, Masahide; Hioki, Atsushi; Nakamura, Mitsuhiro Journal: Inquiry Issue: Volume 58(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of pregabalin‐induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases. (19th December 2018) Authors: Mukai, Ririka; Hasegawa, Shiori; Umetsu, Ryogo; Nakao, Satoshi; Shimada, Kazuyo; Uranishi, Hiroaki; Masuta, Mayuko; Suzuki, Honami; Nishibata, Yuri; Nakamura, Mitsuhiro Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 44:Number 2(2019) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Microplastics contamination in tidelands of the Osaka Bay area in western Japan. (24th November 2019) Authors: Nakao, Satoshi; Ozaki, Asako; Yamazaki, Kazuo; Masumoto, Keiko; Nakatani, Tadashi; Sakiyama, Takanori Journal: Water and environment journal Issue: Volume 34:Number 3(2020) Page Start: 474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis. Issue 4 (29th November 2022) Authors: Tanahashi, Hiroki; Yamaguchi, Kakuhiro; Kurose, Koji; Nakao, Satoshi; Sakamoto, Shinjiro; Horimasu, Yasushi; Masuda, Takeshi; Miyamoto, Shintaro; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Hamada, Hironobu; Oga, Toru; Oka, Mikio; Hattori, Noboru Journal: Respirology Issue: Volume 28:Issue 4(2023) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗